Los Angeles, December 30, 2019 -QY Research recently published a report titled, “Global Cell Image Analysis System Market Size, Status and Forecast 2019-2025”. According to the report, in 2018, the global cell image analysis system market size was US$1395.45 mn and it is expected to reach US$2608.54 mn by the end of 2025, rising at a CAGR of 9.12% during 2019-2025.
Get PDF sample copy of the report at: https://www.qyresearch.com/sample-form/form/1250492/global-cell-image-analysis-system-market
Development of New Drugs to Encourage Heavy Investments in Market
Developments in the healthcare sector has encouraged heavy investments in R&D among developed and developing countries. It is usually used for research to study biological systems such as cell structures and its processes in real time on a large scale through chemical and genetic perturbations. Also, live cell image analysis system provides a more reliable and relevant information than fixed cell microscopy scientist in this field are increasingly adopting this system. Studying these cells can help scientists understand enzyme activity, cellular integrity, localization of molecules, protein trafficking, and exocytosis and endocytosis among others.
Furthermore, the rise of market can be attributed to the demands of development of new drugs, efficient diagnostic facilities, personalized medicine, and prevalence of chronic diseases. These factors are expected to boost the market in the near future.
Academic and Research Institutes Segment to Contribute Majorly in Market Growth
Rising government funding and increasing focus on enhancing the drug is the major reason behind the growth of the academic and research institutes segment in the global cell image analysis system market.
North America to Led Global Cell Image Analysis System Market
North America is expected to dominate the market owing to the rising pharmaceutical and biotechnology industries, high incidents of cancer, government funding for the R&D for new drugs, and development in the cell image analysis system.
Manufacturers to Focus on New Drug Discovery
Sartorius recently signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. According to the proposal they will acquire the label-free biomolecular characterization business, which comprises innovative protein analysis instruments, biosensors and reagents used in drug discovery. It will become an integral part of Sartorius’ bioanalytics unit within its Lab Products & Services division.
The other major manufacturers covered in the market include Sartorius AG, BioTek Instruments, GE Healthcare, Nikon Corporation, BD, Yokogawa Electric Corporation, Thermo Fisher Scientific, PerkinElmer, Leica Microsystems, Merck, Molecular Devices, Olympus Corporation, and others.
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.
QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA – 91748
USA: +1 626 428 8800
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – firstname.lastname@example.org
Web – www.qyresearch.com